Cancer Cause and Prevention Research in Missouri
Cancer Cause and Prevention Research (93.393) awarded $60.9 million to recipients in Missouri in 47 grants from fiscal 2021 to 2025, 1.7% of the program's national total. The Washington University received the most, $55.3 million.
- Awarded in Missouri$60.9 million
- Awards47
- Share of the program1.7%
- Rank among states16th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 16 | $6.5 million |
| FY 2022 | 26 | $11.1 million |
| FY 2023 | 26 | $12.0 million |
| FY 2024 | 31 | $15.2 million |
| FY 2025 | 30 | $16.1 million |
Recipients in Missouri
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Washington University | Colleges and universities | 38 | $55.3 million |
| University of Missouri System | Colleges and universities | 3 | $2.3 million |
| Stowers Institute for Medical Research | Nonprofits | 3 | $1.6 million |
| Childrens Mercy Hospital | Nonprofits | 1 | $1.2 million |
| Saint Louis University | Colleges and universities | 2 | $553,253 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Missouri?
$60.9 million from fiscal 2021 to 2025, across 47 awards. Missouri ranks 16th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Missouri?
The largest recipient is The Washington University, with $55.3 million in 38 awards. Next are University of Missouri System and Stowers Institute for Medical Research.
Can organizations in Missouri apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Missouri
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Broadband Equity, Access, and Deployment Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families